These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Granacher RP; Baldessarini RJ Arch Gen Psychiatry; 1975 Mar; 32(3):375-80. PubMed ID: 1115577 [TBL] [Abstract][Full Text] [Related]
6. Antiparkinson drugs as causal agents in tardive dyskinesia. Kiloh LG; Smith JS; Williams SE Med J Aust; 1973 Sep; 2(12):591-3. PubMed ID: 4149942 [No Abstract] [Full Text] [Related]
7. Adverse effects of antiparkinson drug withdrawal. Jellinek T; Gardos G; Cole JO Am J Psychiatry; 1981 Dec; 138(12):1567-71. PubMed ID: 6118066 [TBL] [Abstract][Full Text] [Related]
8. Reversible toxic psychosis. Hasan MK; Mooney RP Am Fam Physician; 1979 Dec; 20(6):89-92. PubMed ID: 517384 [TBL] [Abstract][Full Text] [Related]
9. Anticholinergic psychosis in a bilingual: a case study. Laski E; Taleporos E Am J Psychiatry; 1977 Sep; 134(9):1038-40. PubMed ID: 900288 [No Abstract] [Full Text] [Related]
10. Olanzapine: a proarrhythmic drug? Gupta N; Malhotra P Can J Psychiatry; 2002 Sep; 47(7):683-4. PubMed ID: 12355682 [No Abstract] [Full Text] [Related]
11. The withdrawal of benztropine mesylate in chronic schizophrenic patients. Baker LA; Cheng LY; Amara IB Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765 [TBL] [Abstract][Full Text] [Related]
12. Heat dyscontrol syndrome in patients receiving antipsychotic, antidepressant and antiparkinson drug therapy. Reimer DR; Mohan J; Nagaswami S J Fla Med Assoc; 1974 Jul; 61(7):573-4. PubMed ID: 4152488 [No Abstract] [Full Text] [Related]
13. Toxic psychosis with antihistamines reversed by physostigmine. Cowen PJ Postgrad Med J; 1979 Sep; 55(646):556-7. PubMed ID: 514934 [TBL] [Abstract][Full Text] [Related]
15. Abuse of antiparkinsonian drugs. Craig DH; Rosen P Ann Emerg Med; 1981 Feb; 10(2):98-100. PubMed ID: 7224257 [TBL] [Abstract][Full Text] [Related]
16. Ethopropazine and benztropine in neuroleptic-induced parkinsonism. Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969 [TBL] [Abstract][Full Text] [Related]
17. Clozapine for drug-induced psychosis in Parkinson's disease. Brown TM N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274 [No Abstract] [Full Text] [Related]
18. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine. Hvizdos AJ; Bennett JA; Wells BG; Rappaport KB; Mendel SA Clin Pharm; 1983; 2(2):174-8. PubMed ID: 6883947 [No Abstract] [Full Text] [Related]
19. [Complications of drug withdrawal from antiparkinson agents and neuroleptics]. Mizon JP; Rosa A Therapie; 1984; 39(4):421-5. PubMed ID: 6148792 [No Abstract] [Full Text] [Related]
20. Toxic psychosis induced by phenothiazine administration in patients with chronic renal failure. Zetin M Clin Nephrol; 1979 Aug; 12(2):95-6. PubMed ID: 527276 [No Abstract] [Full Text] [Related] [Next] [New Search]